News

Alzheimer disease treatment donanemab will be delayed as the FDA plans to convene a committee meeting to evaluate the phase 3 Trailblazer-Alz 2 trial.

Science fiction or reality? Women’s rights take the center stage in today’s discussion, and in the new movie “Dune: Part Two.”

The screening tool includes multiple tests that assess memory, attention, executive function, reaction times, and motor function.

The US Food and Drug Administration has granted breakthrough designation to MindMed’s lysergide d-tartrate program (MM-120) for the treatment of generalized anxiety disorder.

The original STAR*D authors refute claims of a violated protocol.

H. Steven Moffic, MD, views the Dune book and movies through a psychiatric lens.

Contesters of STAR*D discuss the impact and relevance of the study's remission rates.

"For we are a healing and a growing greenhouse..."

The therapy is the first self-neuromodulation device for PTSD approved by the US Food and Drug Administration.

This trial aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of VLS-01 compared with intravenous DMT for treatment-resistant depression.

What are your top 3 ethics issues? Take our survey!

STAR*D trial is one of the most important foundational studies in psychiatry to guide the treatment of unipolar major depression. Get ready to explore a dialogue between the original STAR*D authors and a group of authors who call STAR*D into question.

Remembering the 1-year anniversary of Frank Miller, MD’s death.

“Can I use this at home?” Researchers performed a randomized clinical trial of home-use transcranial direct current stimulation in patients with depression.

Over the last century and even longer, we have taken a useful fossil fuel energy road that has also led to the problematic adverse effects of acute and long-term disasters. Is this reflected in current popular films like “Dune: Part Two”?

From personality disorders and common comorbidities to the effects of abortion bans on mental health, here are highlights from the week in Psychiatric Times.

March is Ethics Awareness Month. How does this time apply to psychiatry? What ethical quandaries do you face in your practice?

What is new in research on ADHD?

The scholarships will support up to 10 students and early career professionals.

“Dune: Part Two” releases today. What social psychiatric implications might it have for our current society?

Write to us now to be part of our series focused on mood disorders this month.

The experts weighed in on a wide variety of psychiatric issues for the February 2024 issue of Psychiatric Times.

Here’s a look back at selections from our February content series on eating disorders.

Here are some updates from the world of psychiatry throughout the month of February.

In this CME article, examine the etiology of poor medical outcomes in borderline personality disorder and learn more about the assessment and management of patients with reported borderline personality disorder who have been admitted medically.

Has psychiatry leaped in advances in the past 50 years?

How do the 4 major chatbots compare for psychiatrists and mental health professionals?

Are you excited for Leap Year?

Does a lack of abortion access fuel mental illness by exacerbating stress, poverty, and domestic violence? Learn more here.

Psychiatric Times discussed the recent research with Anne Marie O'Melia, MD, MS, FAAP, CEDS-S, of the Eating Recovery Center.